Zabicipril

CAS No. 83059-56-7

Zabicipril( —— )

Catalog No. M36247 CAS No. 83059-56-7

Zabicipril is a novel orally available angiotensin-converting enzyme inhibitor, a prodrug with antihypertensive activity following in vivo de-esterification.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 426 Get Quote
5MG 655 Get Quote
10MG 934 Get Quote
25MG 1343 Get Quote
50MG 1812 Get Quote
100MG 2385 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Zabicipril
  • Note
    Research use only, not for human use.
  • Brief Description
    Zabicipril is a novel orally available angiotensin-converting enzyme inhibitor, a prodrug with antihypertensive activity following in vivo de-esterification.
  • Description
    Zabicipril is a novel orally available angiotensin-converting enzyme inhibitor, a prodrug with antihypertensive activity following in vivo de-esterification.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    83059-56-7
  • Formula Weight
    416.51
  • Molecular Formula
    C23H32N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@@H](N[C@H](C(OCC)=O)CCC1=CC=CC=C1)C)(=O)N2[C@H](C(O)=O)C3(CCC2(CC3)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Resorcinolnaphthalei...

    Resorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).

  • H-Val-Pro-Pro-OH

    H-Val-Pro-Pro-OH is an inhibitor of Angiotensin I converting enzyme (ACE)( IC50 : 9 μM).

  • Breviscapin

    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.